HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs.

AuthorsEdoardo Conticini, Elena Bargagli, Marco Bardelli, Giuseppe Domenico Rana, Caterina Baldi, Paolo Cameli, Stefano Gentileschi, David Bennett, Paolo Falsetti, Nicola Lanzarone, Francesca Bellisai, Cristiana Barreca, Roberto D'Alessandro, Luca Cantarini, Bruno Frediani
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 80 Issue 2 Pg. e14 (02 2021) ISSN: 1468-2060 [Electronic] England
PMID32414804 (Publication Type: Letter, Comment)
Chemical References
  • Antirheumatic Agents
  • Synthetic Drugs
Topics
  • Antirheumatic Agents (adverse effects)
  • COVID-19
  • Humans
  • Rheumatic Diseases (drug therapy)
  • SARS-CoV-2
  • Synthetic Drugs (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: